A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Cancer Research Communications|2025Cited by 2
Data from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Unknown|2025Cited by 0
Figure S1 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Unknown|2025Cited by 0
Figure 1 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Serafín Morales et al.|Unknown|2025Cited by 0
Figure 2 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Unknown|2025Cited by 0